Molecular cloning and characterization of SmrA, a novel ABC multidrug efflux pump from Stenotrophomonas maltophilia

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 4, 2009, Pages 731-734

  Al Hamad, Arif ^a   Upton, Mathew ^a   Burnie, James ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

ABC transporters; Antibiotic resistance; Multidrug exporter; Multidrug resistant

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ABC TRANSPORTER; CHLORHEXIDINE; DOXORUBICIN; ETHIDIUM BROMIDE; HOE 33342; NORFLOXACIN; PROTEIN SMRA; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESERPINE; RHODAMINE 6G; TETRACYCLINE; TETRAPHENYLPORPHYRIN DERIVATIVE; TRICLOSAN; UNCLASSIFIED DRUG; VANADATE SODIUM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BROTH DILUTION; CONTROLLED STUDY; DISK DIFFUSION; DRUG UPTAKE; FLUORESCENCE; GENE EXPRESSION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PROTEIN ANALYSIS; PROTEIN MOTIF; PROTEIN TRANSPORT; SEQUENCE ANALYSIS; STENOTROPHOMONAS MALTOPHILIA;

ANTI-BACTERIAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; CLONING, MOLECULAR; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; NORFLOXACIN; STENOTROPHOMONAS MALTOPHILIA;

EID: 70349470750     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp271     Document Type: Article

References (11)

1. Hanes SD, Demirkan K, Tolley E et al. Risk factors for lateonset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin Infect Dis 2002; 35: 228-35.
2. Crossman LC, Gould VC, Dow JM et al. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 2008; 9: R74.
3. Alonso A, Martinez JL. Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2000; 44: 3079-86.
4. Walker JE, Saraste M, Runswick MJ et al. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J 1982; 1: 945-51.
5. Hyde SC, Emsley P, Hartshorn MJ et al. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature 1990; 346: 362-5.
6. Kimura Y, Morita SY, Matsuo M et al. Mechanism of multidrug recognition by MDR1/ABCB1. Cancer Sci 2007; 98: 1303-10.
7. van Veen HW, Venema K, Bolhuis H et al. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc Natl Acad Sci USA 1996; 93: 10668-72.
8. Huda N, Lee EW, Chen J et al. Molecular cloning and characterization of an ABC multidrug efflux pump, VcaM, in Non-O1 Vibrio cholerae. Antimicrob Agents Chemother 2003; 47: 2413-7.
9. O'Neill AJ, Bostock JM, Moita AM et al. Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid. J Antimicrob Chemother 2002; 50: 839-48.
10. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically - Seventh Edition: Approved Standard M7-A7. CLSI, Wayne, PA, USA, 2006.
11. Mortimer PGS, Piddock LJV. A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 1991; 28: 639-53.